Ocean View, Delaware, July 03, 2017 (GLOBE NEWSWIRE) --
The Industry Analysis report “Diabetic retinopathy Market By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Management (Anti VEGF Drug, Intra-ocular Steroid Injections, Laser Surgeries, Vitrectomy), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Japan, China, Brazil and South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” by Global Market Insights, Inc. says Diabetic Retinopathy Market share is projected to cross USD 11 billion by 2023.
Increasing incidence and prevalence of diabetes, rapid growth in incidence of blindness associated with diabetes, due to complication associated with Diabetic Retinopathy, increase in number of geriatric population globally, and enhanced awareness for early diagnosis of Diabetic Retinopathy will be key factors for strengthening the demand global Diabetic Retinopathy Market
Non-proliferative Diabetic Retinopathy (NPDR) being the initial stage of Diabetic Retinopathy accounts for maximum market share over the forecast period. While, proliferative Diabetic Retinopathy PDR is caused when the NPDR goes untreated and PDR may cause more extreme vision loss than NPDR because it can affect peripheral and central vision.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/486
Non-proliferative diabetic retinopathy accounted for over 70% of the global market in 2015. Being earlier stage of diabetic retinopathy patients avoid further complications and try and get cured before their vision is permanently damaged. LATAM is set account for over 10% of the global market share in throughout the forecast period. Disposable income and other demographic trends, as well as strong awareness level, make Brazil attractive in terms of availability large patient pool and supply chain accessible from U.S.
Anti-VEGF accounted for over 90% of market share during the forecast period and will lose its market share collectively to intraocular steroid injection, laser surgery, and vitrectomy.
Browse key industry insights spread across 73 pages with 32 market data tables & 8 figures & charts from the report, “Diabetic retinopathy Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report
Germany Anti-VEGF market size was over USD 500 million in 2015. Optimistic indicators from medical industry for curing cataracts, macular degeneration, and preventing heart diseases fueled demand. Healthcare industry expansion along with raise in consumer affordability have positively affect the regional growth.
Asia Pacific Diabetic Retinopathy Market share will witness significant gains increasing at 5% CAGR. Favorable clinical guidelines and government initiatives are expected to increase the diagnosis and treatment rate, thereby fueling the growth.
Lack of skilled ophthalmologists coupled with increasing incidences of diabetes mellitus are the crucial growth drivers for of diabetic retinopathy market in Brazil. MEA Diabetic Retinopathy Market has witnessed notable growth. South Africa dominates the industry, increase in the geriatric population will propel the market for diabetic retinopathy.
In terms of terrestrial presence major companies include, Actavis, Alimera Sciences, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Glycadia Pharmaceuticals, Kowa Group, Novartis AG, Regeneron Pharmaceuticals, Sirnaomics Incorporation and ThromboGenics.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/486
Browse Related Reports:
- Antidiabetics Market Size 2016 – 2023
Antidiabetics Market size was USD 51.1 billion in 2015, and expected to grow at 10% CAGR in coming time. Growing prevalence of lifestyle induced disorders such as obesity, and type I, type II diabetes will have a significant impact on the global antidiabetics market evolution.
https://www.gminsights.com/industry-analysis/antidiabetics-market
- Insulin Delivery Devices Market Size 2017 – 2024
Insulin Delivery Devices Market size is expected to witness a handsome growth by 2024. Increasing diabetes prevalence will drive insulin delivery devices market growth throughout the forecast period.
https://www.gminsights.com/industry-analysis/insulin-delivery-devices-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter